The use of high-dose intravenous immunoglobulins in Guillain-Barré syndrome.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 1566990.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A patient with severe Guillain-Barré syndrome responded to treatment with high-dose intravenous immunoglobulins. It is suggested, on the basis of recent case reports, that immunoglobulins may have an important rôle in the future treatment of this immune-mediated disease.
Medical subject headings
- Immunization, Passive
- Polyradiculoneuropathy